{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:21:18Z","timestamp":1767997278052,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012268","name":"Proteomass Scientific Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Fundacao para a Ciencia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"LAQV-REQUIMTE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.talanta.2024.126589","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T23:57:36Z","timestamp":1722470256000},"page":"126589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Dithiothreitol-based protein equalisation in the context of multiple myeloma: Enhancing proteomic analysis and therapeutic insights"],"prefix":"10.1016","volume":"279","author":[{"given":"Ines F.","family":"Domingos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis B.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5582-5446","authenticated-orcid":false,"given":"Carlos","family":"Lodeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Gerivaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gali","family":"Prag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Micaglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2210-2174","authenticated-orcid":false,"given":"Eli","family":"Muchtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo M.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose L.","family":"Capelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.talanta.2024.126589_bib1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.talanta.2024.126589_bib2","doi-asserted-by":"crossref","first-page":"e1406","DOI":"10.1634\/theoncologist.2020-0141","article-title":"\u2018Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic Resources, and","volume":"25","author":"Ludwig","year":"2020","journal-title":"Patient Empowerment\u2019, Oncologist"},{"issue":"1","key":"10.1016\/j.talanta.2024.126589_bib3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/cam4.3444","article-title":"Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial\u2010ethnic group, United States 2003\u20102016","volume":"10","author":"Ellington","year":"2021","journal-title":"Cancer Med."},{"issue":"16","key":"10.1016\/j.talanta.2024.126589_bib4","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood.2021015161","article-title":"Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma","volume":"139","author":"Anderson","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.talanta.2024.126589_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.842200","article-title":"Single-cell proteomics and tumor RNAseq identify novel pathways associated with clofazimine sensitivity in PI- and IMiD- resistant myeloma, and putative stem-like cells","volume":"12","author":"Kumar","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.talanta.2024.126589_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90149-y","article-title":"Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients","volume":"11","author":"Tierney","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.talanta.2024.126589_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338672","article-title":"Combinatory strategy using nanoscale proteomics and machine learning for T cell subtyping in peripheral blood of single multiple myeloma patients","volume":"1173","author":"Ye","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.talanta.2024.126589_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.talanta.2017.11.063","article-title":"Dithiothreitol-based protein equalization technology to unravel biomarkers for bladder cancer","volume":"180","author":"Ara\u00fajo","year":"2018","journal-title":"Talanta"},{"issue":"18","key":"10.1016\/j.talanta.2024.126589_bib9","doi-asserted-by":"crossref","first-page":"7467","DOI":"10.1039\/C5AY00620A","article-title":"Matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry-based profiling as a step forward in the characterization of peritoneal dialysis effluent","volume":"7","author":"Ara\u00fajo","year":"2015","journal-title":"Anal. Methods"},{"key":"10.1016\/j.talanta.2024.126589_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.talanta.2014.02.050","article-title":"Sequential depletion coupled to C18 sequential extraction as a rapid tool for human serum multiple profiling","volume":"125","author":"Fern\u00e1ndez-Costa","year":"2014","journal-title":"Talanta"},{"issue":"21","key":"10.1016\/j.talanta.2024.126589_bib11","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1002\/elps.201100183","article-title":"A comparison of depletion versus equalization for reducing high\u2010abundance proteins in human serum","volume":"32","author":"Fern\u00e1ndez","year":"2011","journal-title":"Electrophoresis"},{"issue":"1","key":"10.1016\/j.talanta.2024.126589_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1477-5956-10-55","article-title":"Sequential depletion of human serum for the search of osteoarthritis biomarkers","volume":"10","author":"Fern\u00e1ndez-Costa","year":"2012","journal-title":"Proteome Sci."},{"key":"10.1016\/j.talanta.2024.126589_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.talanta.2017.11.063","article-title":"Dithiothreitol-based protein equalization technology to unravel biomarkers for bladder cancer","volume":"180","author":"Ara\u00fajo","year":"2018","journal-title":"Talanta"},{"issue":"8","key":"10.1016\/j.talanta.2024.126589_bib14","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1021\/ac504689z","article-title":"Fast and sensitive total protein and peptide assays for proteomic analysis","volume":"87","author":"Wi\u015bniewski","year":"2015","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.talanta.2024.126589_bib15","doi-asserted-by":"crossref","first-page":"pp1","DOI":"10.5584\/jiomics.v14i1.229","article-title":"DTT protein equalization and Tryptophan protein quantification as a powerful tool in analytical proteomics","volume":"14","author":"Domingos","year":"2024","journal-title":"JIOMICS"},{"issue":"8","key":"10.1016\/j.talanta.2024.126589_bib16","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/pmic.201400449","article-title":"Visualization of LC\u2010MS\/MS proteomics data in MaxQuant","volume":"15","author":"Tyanova","year":"2015","journal-title":"Proteomics"},{"issue":"4","key":"10.1016\/j.talanta.2024.126589_bib17","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/pr101065j","article-title":"Andromeda: a peptide search engine integrated into the MaxQuant environment","volume":"10","author":"Cox","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.talanta.2024.126589_bib18","first-page":"133","article-title":"\u2018Perseus: a bioinformatics platform for integrative analysis of proteomics data","author":"Tyanova","year":"2018","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.talanta.2024.126589_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"\u2018The Perseus computational platform for comprehensive analysis of (prote)omics data\u2019","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.talanta.2024.126589_bib20","first-page":"373","article-title":"Multiple myeloma: diagnosis and treatment","volume":"95","author":"Michels","year":"2017","journal-title":"Am. Fam. Physician"},{"issue":"1","key":"10.1016\/j.talanta.2024.126589_bib21","doi-asserted-by":"crossref","DOI":"10.36959\/832\/392","article-title":"Amyloidosis and the kidney","volume":"2","author":"Allison B","year":"2017","journal-title":"Annals of Nephrology"},{"issue":"2","key":"10.1016\/j.talanta.2024.126589_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02983377","article-title":"Survival and proliferation factors of normal and malignant plasma cells","volume":"78","author":"Klein","year":"2003","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.talanta.2024.126589_bib23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.talanta.2024.126589_bib24","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/cancers11101618","article-title":"A comprehensive review on MAPK: a promising therapeutic target in cancer","volume":"11","author":"Braicu","year":"2019","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.talanta.2024.126589_bib25","doi-asserted-by":"crossref","first-page":"8323","DOI":"10.3390\/ijms21218323","article-title":"Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer","volume":"21","author":"Patergnani","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.talanta.2024.126589_bib26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","author":"Markiewski","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.talanta.2024.126589_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12964-021-00781-4","article-title":"Pathophysiological role of calcium channels and transporters in the multiple myeloma","volume":"19","author":"Li","year":"2021","journal-title":"Cell Commun. Signal."},{"issue":"3","key":"10.1016\/j.talanta.2024.126589_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00277-007-0375-6","article-title":"Cholesterol levels in patients with multiple myeloma","volume":"87","author":"Yavasoglu","year":"2008","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.talanta.2024.126589_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/08820538.2019.1687738","article-title":"Amyloidosis and ocular involvement: an overview","volume":"35","author":"Dammacco","year":"2020","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.talanta.2024.126589_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.critrevonc.2018.07.003","article-title":"Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: a pooled analysis","volume":"130","author":"Bringhen","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.talanta.2024.126589_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3892\/or.2022.8443","article-title":"HSP90 inhibitors and cancer: prospects for use in targeted therapies","volume":"49","author":"Li","year":"2023","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.talanta.2024.126589_bib32","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/0008-5472.CAN-11-1780","article-title":"Enhanced apoptosis and tumor growth suppression elicited by combination of MEK (selumetinib) and mTOR kinase inhibitors (AZD8055)","volume":"72","author":"Holt","year":"2012","journal-title":"Cancer Res."},{"issue":"9686","key":"10.1016\/j.talanta.2024.126589_bib33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma","volume":"374","author":"Raab","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.talanta.2024.126589_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12882-020-02226-5","article-title":"Two cases of carfilzomib\u2010induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma","volume":"22","author":"Rassner","year":"2021","journal-title":"BMC Nephrol."},{"issue":"11","key":"10.1016\/j.talanta.2024.126589_bib35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4103\/1947-2714.170600","article-title":"Hypercalcemia of malignancy: an update on pathogenesis and management","volume":"7","author":"Mirrakhimov","year":"2015","journal-title":"N. Am. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.talanta.2024.126589_bib36","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/s41375-020-01021-3","article-title":"Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse","volume":"35","author":"Dimopoulos","year":"2021","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.talanta.2024.126589_bib37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2217\/fon-2021-1176","article-title":"Real-world outcomes of pomalidomide therapy after lenalidomide induction in relapsed\/refractory multiple myeloma","volume":"18","author":"Mark","year":"2022","journal-title":"Future Oncol."},{"issue":"Apr","key":"10.1016\/j.talanta.2024.126589_bib38","article-title":"Drug targeting of genomic instability in multiple myeloma","volume":"11","author":"Beksac","year":"2020","journal-title":"Front. Genet."},{"issue":"52","key":"10.1016\/j.talanta.2024.126589_bib39","doi-asserted-by":"crossref","first-page":"90501","DOI":"10.18632\/oncotarget.18765","article-title":"The therapeutic potential of cell cycle targeting in multiple myeloma","volume":"8","author":"Maes","year":"2017","journal-title":"Oncotarget"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914024009688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914024009688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T07:40:47Z","timestamp":1728546047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914024009688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":39,"alternative-id":["S0039914024009688"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2024.126589","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dithiothreitol-based protein equalisation in the context of multiple myeloma: Enhancing proteomic analysis and therapeutic insights","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2024.126589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"126589"}}